Target intelligence / Profile preview

Beta-amylase

Molecular classification
Enzyme, Glycoside hydrolase family 14 (GH14)
01

Overview

Beta-amylase (EC 3.2.1.2; systematic name 4-α-D-glucan maltohydrolase) is an enzyme classified as an exohydrolase that catalyzes the hydrolysis of successive maltose units from the non-reducing ends of polysaccharides, such as starch and glycogen, by cleaving α-1,4 glycosidic bonds[1][2][3][4]. Beta-amylase is prolific in plants (notably seeds and fruit), bacteria, and fungi, but is not found in animal tissues except via microbial presence in the digestive tract[3]. The enzyme belongs to glycoside hydrolase family 14 (GH14), with different isoforms and oligomeric states existing in various species[1][2]. Its activity results in the release of beta-maltose and is key in processes like seed germination and fruit ripening, where starch is converted to maltose, creating a sweeter taste[3]. While beta-amylase is widely studied for its biochemical and industrial roles, it is not a typical drug target or known marker for therapeutic intervention in human diseases. The described enzymatic mechanism involves key residues acting as general acids and bases to facilitate cleavage of the glycosidic bond[1].

Other names
saccharogen amylaseglycogenasebeta-amylaseβ-amylase
02

Biological functions

Starch catabolismCarbohydrate metabolismHydrolysis of α-1,4 glycosidic bondsProduction of maltose from polysaccharides
03

Disease associations

Other (not considered a major human therapeutic target or major role in human diseases)

Beyond the preview

Go deeper on Beta-amylase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-amylase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call